Acrifab Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 25-12-2024
- Paid Up Capital ₹ 0.10 M
as on 25-12-2024
- Company Age 11 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.50 M
as on 25-12-2024
- Satisfied Charges ₹ 3.00 M
as on 25-12-2024
- Revenue 58.11%
(FY 2022)
- Profit 482.96%
(FY 2022)
- Ebitda 494.78%
(FY 2022)
- Net Worth 104.82%
(FY 2022)
- Total Assets 68.99%
(FY 2022)
About Acrifab
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.50 M. The company has closed loans amounting to ₹3.00 M, as per Ministry of Corporate Affairs (MCA) records.
Bhavesh Gohil and Pravinaben Gohil serve as directors at the Company.
- CIN/LLPIN
U29194GJ2013PTC074568
- Company No.
074568
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Apr 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Acrifab Private Limited offer?
Acrifab Private Limited offers a wide range of products and services, including Camera & Photography Equipments, Industrial Cameras, Metallurgical & Lab Microscopes, Digital Microscope, Marking and Stamping Machines, Coding Machine, Street, Flood and Commercial Lights, Spot Lights, Data Entry & Data Processing Service, Data Digitization.
Who are the key members and board of directors at Acrifab?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Bhavesh Gohil | Director | 18-Apr-2013 | Current |
Pravinaben Gohil | Director | 18-Apr-2013 | Current |
Financial Performance of Acrifab.
Acrifab Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 58.11% increase. The company also saw a substantial improvement in profitability, with a 482.96% increase in profit. The company's net worth Soared by an impressive increase of 104.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Acrifab?
In 2020, Acrifab had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Neurobot Technology Private LimitedActive 1 year 6 months
Bhavesh Gohil and Pravinaben Gohil are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Hdfc Bank Limited Creation Date: 10 Jun 2016 | ₹1.50 M | Open |
Yes Bank Limited Creation Date: 17 Jun 2017 | ₹3.00 M | Satisfied |
How Many Employees Work at Acrifab?
Unlock and access historical data on people associated with Acrifab, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Acrifab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Acrifab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.